Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

22.98
-0.6700-2.83%
Post-market: 22.980.00000.00%18:36 EDT
Volume:3.89M
Turnover:89.58M
Market Cap:4.68B
PE:-8.57
High:24.04
Open:23.57
Low:22.79
Close:23.65
52wk High:29.25
52wk Low:12.72
Shares:203.53M
Float Shares:89.02M
Volume Ratio:3.19
T/O Rate:4.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6799
EPS(LYR):-2.7303
ROE:-69.35%
ROA:-41.33%
PB:4.74
PE(LYR):-8.42

Loading ...

Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025

THOMSON REUTERS
·
Feb 06

Earning Preview: Immunovant, Inc. this quarter’s revenue is expected to increase by 0.00%, and institutional views are bullish

Earnings Agent
·
Jan 30

Immunovant Inc. to Announce Third Quarter Financial Results and Business Update

Reuters
·
Jan 26

Roivant Sciences President and Immunovant CEO Eric Venker Reports Disposal of Common Shares

Reuters
·
Jan 15

Immunovant price target raised to $22 from $16 at Truist

TIPRANKS
·
Jan 08

Immunovant Raised to Outperform From Peer Perform by Wolfe Research

Dow Jones
·
Jan 06

Roivant Sciences President and Immunovant CEO Eric Venker Reports Disposal of Common Shares

Reuters
·
Dec 30, 2025

Immunovant (IMVT): Reassessing Valuation After a $550 Million Follow-On Equity Raise

Simply Wall St.
·
Dec 21, 2025

Immunovant (IMVT) Is Up 14.0% After $550 Million Follow-On Backed By Roivant Sciences - What's Changed

Simply Wall St.
·
Dec 15, 2025

Immunovant (IMVT): Reassessing Valuation After $550 Million Follow-On Offering for IMVT-1402 Launch

Simply Wall St.
·
Dec 12, 2025

Immunovant Inc - Files for Offering of 26,200,000 Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Dec 12, 2025

Roivant Sciences President and Immunovant CEO Eric Venker Reports Disposal of Common Shares

Reuters
·
Dec 12, 2025

Roivant Signals Major Pipeline Momentum With Accelerated Timelines

Benzinga_recent_news
·
Dec 12, 2025

Roivant Sciences Fast-Tracks Key Drug Development Programs

MT Newswires Live
·
Dec 11, 2025

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday as Oracle Results Sour Investor Mood

MT Newswires Live
·
Dec 11, 2025

Immunovant Inc - Offers 26.2 Mln Shares at $21.00 per Share

THOMSON REUTERS
·
Dec 11, 2025

Press Release: Immunovant Announces Pricing of $550 Million Common Stock Financing

Dow Jones
·
Dec 11, 2025

Immunovant (IMVT): Assessing Valuation Following R&D Leadership Restructuring and CMO Departure

Simply Wall St.
·
Nov 26, 2025

Immunovant Chief Medical Officer Michael Geffner Steps Down

MT Newswires Live
·
Nov 21, 2025

Immunovant Chief Medical Officer Michael Geffner Departs Amid R&D Restructuring

Reuters
·
Nov 21, 2025